Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TRIHEXYPHENIDYL vs TRILACICLIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TRIHEXYPHENIDYL vs TRILACICLIB: Safety Overview

Metric TRIHEXYPHENIDYL TRILACICLIB
Total FAERS Reports 1,782 226
Deaths Reported 334 29
Death Rate 18.7% 12.8%
Hospitalizations 927 96
Average Patient Age 46.3 yrs 62.2 yrs
% Female Patients 35.8% 43.9%
FDA Approval Date Approved Prior to Jan 1, 1982 Feb 12, 2021
Manufacturer Natco Pharma Limited Pharmacosmos Therapeutics Inc.
Route ORAL INTRAVENOUS
Marketing Status Discontinued Prescription